Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions.

On the day following the report, MSOS ETF (ARCA: MSOS) surged 21%. Notable companies also experienced remarkable gains, with State House Holdings Inc. (OTC: STHZF) skyrocketing by 74%, Columbia Care (OTC: CCHWF) witnessing a 38% boost, Jushi (OTC: JUSH) rising by 32% and Ayr Wellness (OTC: AYRWF) showing a 29% increase.

Analysis firm Zuanic & Associates (Z&A), in a recent report, says the news is a potentially game-changing development.

Delve Deeper into Cannabis Regulation at the Benzinga Cannabis Capital Conference in Chicago on September 27-28. Connect with Z&A's Pablo Zuanic and engage in discussions about the recent Biden Administration's recommendation on cannabis regulation.

Navigating Regulatory Shifts: A Bullish Outlook Amid Uncertainties

The report presents an optimistic "bull case narrative" for the industry, and argues …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.